(EYE dur SUL fase) Brand: Elaprase
• Idursulfase may improve walking capacity in people with Hunter syndrome. However, idursulfase is not a cure for this condition.
• Some people receiving an idursulfase injection have had a reaction to the infusion (when the medication is injected into the vein). Speak your caregiver right away if you feel dizzy, light-headed, or have hives, seizure (convulsions), trouble breathing, or swelling of your person, lips, tongue, or throat.
• It may still be possible for you to receive idursulfase even after you have had a reaction to it. There are another medications that can be given to you till your idursulfase infusion to help prevent any reaction symptoms.
• You may be more likely to have a reaction to idursulfase if you have a breathing mess. Speak your doctor if you have asthma or another lung disease.
• Your name may need to be listed on a Hunter Outcome Survey while you are using this medicine. The purpose of this registry is to track the progression of this mess and the effects that idursulfase has on long-term treatment of Hunter syndrome.
• Idursulfase is used to treat some of the symptoms of a genetic condition called Hunter's syndrome. Hunter syndrome is also called mucopolysaccharidosis (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis).
• Hunter syndrome is a metabolic mess in which the body lacks the enzyme needed to interrupt down determined sugars and proteins. These substances can build up in the body, causing enlarged organs, emergency bone structure, changes in facial parameters, breathing problems, heart problems, vision loss, and changes in mental or physical abilities.
• Idursulfase may improve walking capacity in people with this condition. However, this medicine is not a cure for Hunter syndrome.
• Idursulfase may also be used for purposes not listed in this medicine guide.
• You must not receive this medicine if you are allergic to idursulfase.
• Till receiving idursulfase, speak your doctor if you are allergic to any drugs, or if you have asthma or another breathing disorder.
• You may be more likely to have a reaction to idursulfase if you have a breathing mess. You may need to receive another medications to prevent an symptoms of a reaction to idursulfase. Follow your doctor's instructions.
• Your name may need to be listed on a Hunter Outcome Survey while you are using this medicine. The purpose of this registry is to track the progression of this mess and the effects that idursulfase has on long-term treatment of Hunter syndrome.
• FDA pregnancy category C. This medicine may be deleterious to an unborn child. Speak your doctor if you are pregnant or plan to become pregnant during treatment.
• It is not known whether idursulfase passes into breast milk or if it could harm a nursing child. Do not use this medicine without telling your doctor if you are breast-feeding a baby.
• Idursulfase is given as an injection through a needle placed into a vein. You will most likely receive this injection in a clinic or hospital setting. Idursulfase is generally given once for week.
• The medication should be given slowly through an IV infusion, and can take up to 3 hours to complete.
• Call your doctor if you miss an appointment for your idursulfase injection.
• Search abnormal medical attention if you think you have received too many of this medicine.
• Symptoms of an idursulfase overdose are not known.
• Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are receiving idursulfase.
• Some people receiving a idursulfase injection have had a reaction to the infusion (when the medication is injected into the vein). Speak your caregiver right away if you feel dizzy, light-headed, or have hives, seizure (convulsions), trouble breathing, or swelling of your person, lips, tongue, or throat.
• It may still be possible for you to receive idursulfase even after you have had a reaction to it. There are another medications that can be given to you till your idursulfase infusion to help prevent any reaction symptoms.
• Call your doctor at once if you have any of these serious side effects:
· worsened asthma;
· uneven heartbeats;
· blue lips or fingernails;
· fever;
· vision problems; or
· heighten blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure).
• Smaller serious side effects may include:
· joint pain;
· pain in your arms or legs;
· headache;
· itching, mild skin rash; or
· weakness.
• This is not a complete list of side effects and others may occur. Speak your doctor about any unusual or bothersome side effect. You may message side effects to FDA at 1-800-FDA-1088.
• There may be another drugs that can interact with idursulfase. Speak your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal commodity, and drugs predesigned by another doctors. Do not start a new medicine without telling your doctor.
• Your doctor or pharmacist can provide more information about idursulfase.
Remember, hold this and all another medicines out of the reach of children, never share your medicines with others, and use this medicine only for the indication prescribed.
Disclaim: Each effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses external of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way must be construed to indicate that the drug or drug combination is safety, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the help of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.